Business Description
Sysmex Corp
ISIN : JP3351100007
Description
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.21 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.48 | |||||
| Interest Coverage | 39.14 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 8.38 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.7 | |||||
| 3-Year EBITDA Growth Rate | 11.1 | |||||
| 3-Year EPS without NRI Growth Rate | 10.7 | |||||
| 3-Year FCF Growth Rate | -0.5 | |||||
| 3-Year Book Growth Rate | 11.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.05 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -26.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | |||||
| Quick Ratio | 2.27 | |||||
| Cash Ratio | 0.62 | |||||
| Days Inventory | 139.05 | |||||
| Days Sales Outstanding | 104.07 | |||||
| Days Payable | 50.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 3.6 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.59 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.16 | |||||
| Operating Margin % | 17.32 | |||||
| Net Margin % | 10.28 | |||||
| FCF Margin % | 4.43 | |||||
| ROE % | 11.33 | |||||
| ROA % | 8.37 | |||||
| ROIC % | 11.42 | |||||
| ROC (Joel Greenblatt) % | 29.21 | |||||
| ROCE % | 16.15 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 35.18 | |||||
| PE Ratio without NRI | 35.18 | |||||
| Shiller PE Ratio | 38.61 | |||||
| Price-to-Owner-Earnings | 37.07 | |||||
| PEG Ratio | 5.17 | |||||
| PS Ratio | 3.62 | |||||
| PB Ratio | 3.88 | |||||
| Price-to-Tangible-Book | 5.13 | |||||
| Price-to-Free-Cash-Flow | 88.83 | |||||
| Price-to-Operating-Cash-Flow | 23.39 | |||||
| EV-to-EBIT | 22.13 | |||||
| EV-to-Forward-EBIT | 17.55 | |||||
| EV-to-EBITDA | 14.88 | |||||
| EV-to-Forward-EBITDA | 12.93 | |||||
| EV-to-Revenue | 3.57 | |||||
| EV-to-Forward-Revenue | 3.2 | |||||
| EV-to-FCF | 87.49 | |||||
| Price-to-Projected-FCF | 2.6 | |||||
| Price-to-DCF (Earnings Based) | 4.96 | |||||
| Price-to-DCF (FCF Based) | 14.2 | |||||
| Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.76 | |||||
| Price-to-Graham-Number | 2.83 | |||||
| Price-to-Net-Current-Asset-Value | 10.94 | |||||
| Earnings Yield (Greenblatt) % | 4.52 | |||||
| FCF Yield % | 1.14 | |||||
| Forward Rate of Return (Yacktman) % | 10.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sysmex Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 54,333.451 | ||
| EPS (TTM) (MXN) | 8.866 | ||
| Beta | 0 | ||
| Volatility % | 20.42 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0.000022 | ||
| 20-Day SMA (MXN) | 921.96 | ||
| 12-1 Month Momentum % | -26.12 | ||
| 52-Week Range (MXN) | 921.96 - 1247.91 | ||
| Shares Outstanding (Mil) | 623.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sysmex Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sysmex Corp Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sysmex Corp Frequently Asked Questions
What is Sysmex Corp(MEX:6869)'s stock price today?
The current price of MEX:6869 is MXN921.96. The 52 week high of MEX:6869 is MXN1247.91 and 52 week low is MXN921.96.
When is next earnings date of Sysmex Corp(MEX:6869)?
The next earnings date of Sysmex Corp(MEX:6869) is .
Does Sysmex Corp(MEX:6869) pay dividends? If so, how much?
Sysmex Corp(MEX:6869) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers